EXECUTIVE ENGAGEMENTS
OUTREACH
3581
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
643
Interactions with Platform & by Email
PARTICIPANTS
107
Unique # Participated
VALIDATIONS
48
Responses Validated*
COMPETITORS
46
Responses Validated*
BRANDS
265
Responses Validated*
* Login for a full stack data experience
DATE
SEP 2020
TABLES
159
PAGES
235
EDITION
7
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.
The Cell Viability Assays market in the U.S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.We bring years of research experience to this 7th edition of our report. The 235-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
Abcam PLC; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; BioTek Instruments, Inc.; Biotium, Inc.; Creative Bioarray; Danaher Corporation; GE Healthcare; Merck KgaA; PerkinElmer, Inc.; Promega Corporation; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Uses) » Product Type (Consumables, Instruments)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Cell Viability Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cell Viability Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cell Viability Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Cell Viability Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Consumables (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Consumables (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Consumables (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Instruments (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Instruments (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Instruments (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Basic Research (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 |
| Basic Research (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 |
| Basic Research (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 |
| Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Drug Discovery & Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Drug Discovery & Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Drug Discovery & Development (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Clinical & Diagnostic Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Clinical & Diagnostic Applications (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Clinical & Diagnostic Applications (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 |
| Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 |
| Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Hospital & Diagnostic Laboratories (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 |
| Hospital & Diagnostic Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Hospital & Diagnostic Laboratories (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Cell Viability Assays Market Share (in %) by Company: 2019 & 2025 |
| United States Cell Viability Assays Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027 |
| Cell Viability Assays Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019 |
| United States Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| United States Cell Viability Assays Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 |
| Cell Viability Assays Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| United States Cell Viability Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019 |
| Cell Viability Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027 |
| Canadian Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2012-2019 |
| Cell Viability Assays Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027 |
| Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Canadian Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Canadian Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019 |
| Japanese Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Japanese Cell Viability Assays Market in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Japanese Cell Viability Assays Market in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Historic Market Analysis in China in US$ Million by Product Type: 2012-2019 |
| Chinese Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market Review in China in US$ Million by Application: 2012-2019 |
| Chinese Cell Viability Assays Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Chinese Demand for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market Review in China in US$ Million by End-Use: 2012-2019 |
| Chinese Cell Viability Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Cell Viability Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Cell Viability Assays Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Cell Viability Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Cell Viability Assays Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027 |
| Cell Viability Assays Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019 |
| European Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| European Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| European Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| FRANCE |
| Cell Viability Assays Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2012-2019 |
| French Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 |
| French Cell Viability Assays Historic Market Review in US$ Million by Application: 2012-2019 |
| French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027 |
| French Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2012-2019 |
| French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| GERMANY |
| Cell Viability Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027 |
| German Cell Viability Assays Historic Market Analysis in US$ Million by Product Type: 2012-2019 |
| German Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| German Cell Viability Assays Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 |
| German Cell Viability Assays Market in Retrospect in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019 |
| Italian Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market Review in Italy in US$ Million by Application: 2012-2019 |
| Italian Cell Viability Assays Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Italian Demand for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market Review in Italy in US$ Million by End-Use: 2012-2019 |
| Italian Cell Viability Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019 |
| United Kingdom Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| United Kingdom Cell Viability Assays Market in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| United Kingdom Cell Viability Assays Market in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Cell Viability Assays Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by Application: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| REST OF WORLD |
| Rest of World Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027 |
| Rest of World Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2012-2019 |
| Cell Viability Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027 |
| Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Rest of World Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Rest of World Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 46 |
| V. CURATED RESEARCH |
